Original Research
Published on 02 Dec 2022
Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report
in Bone Research

- 2,996 views
- 1 citation













